Here's What You May Have Missed About Abcam (ABCM)

Shares of Health Care sector company Abcam moved 0.3% today, and are now trading at a price of $22.51. The mid-cap stock's daily volume was 1,247,930 compared to its average volume of 1,815,825. The S&P 500 index returned a -1.0% performance.

Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. The company is based in Cambridge and has 1,760 full time employees. Its market capitalization is $5,171,064,832.

5 analysts are following Abcam and have set target prices ranging from $17.05 to $40.12 per share. On average, they have given the company a rating of buy. At today's prices, ABCM is trading -16.26% away from its average analyst target price of $26.88 per share.

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cashflow ($ k) YoY Growth (%)
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.